Market Cap 653.38M
Revenue (ttm) 65.12M
Net Income (ttm) -54.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -84.09%
Debt to Equity Ratio 0.00
Volume 760,200
Avg Vol 502,534
Day's Range N/A - N/A
Shares Out 43.36M
Stochastic %K 3%
Beta N/A
Analysts Strong Sell
Price Target $23.55

Company Profile

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without t...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 427 7785
Address:
11 Hughes, Irvine, United States
jheerdink
jheerdink Jun. 30 at 4:15 PM
$MODD Modular Medical (Nasdaq: MODD) Unveils Updated Investor Presentation, Emphasizing Disruptive Business Model and Near-Term Milestones https://vistapglobal.com/modular-medical-nasdaq-modd-unveils-updated-investor-presentation-emphasizing-disruptive-business-model-and-near-term-milestones/ $DXCM $BBNX
0 · Reply
P3acemaker
P3acemaker Jun. 25 at 10:05 PM
$BBNX holy shit look at the short interest on this baby - 18%!!!! Which would take 13 days to cover at current volume. Schwab says this stock is hard to borrow so it's not like they can stay short forever. This is an extremely bullish sign and partly accounts for the recent price drop IMO https://fintel.io/ss/us/bbnx
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 4:21 PM
$BBNX teams up with $ABT — is this the game-changer for diabetes care? 🤔 🔗 Strategic agreement to integrate iLet Bionic Pancreas with Abbott's dual glucose-ketone sensor 🚀 Aiming to enhance patient outcomes and simplify diabetes management 🏆 Positions BBNX to capture more of the growing AID market Opportunity assessment here 👉 https://www.zacks.com/commentary/2535909/bbnx-stock-may-gain-from-abbott-deal-to-advance-ilet-integration?cid=sm-stocktwits-2-2535909-body&ADID=SYND_STOCKTWITS_TWEET_2_2535909_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 3:08 PM
$BBNX just teamed up with Abbott — here's why that matters 👀 Beta Bionics is integrating its iLet system with a dual sensor to simplify and improve diabetes care, a move that could drive adoption and upside. Full story on the potential impact here 👉 https://www.zacks.com/stock/news/2535909/bbnx-stock-may-gain-from-abbott-deal-to-advance-ilet-integration?cid=sm-stocktwits-2-2535909-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2535909_TEASER
0 · Reply
IN0V8
IN0V8 Jun. 16 at 8:25 PM
$BBNX Buying opportunity Truist Securities initiates coverage with buy rating Truist Securities initiates coverage with target price $26.00
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 4:06 PM
Truist Securities has updated their rating for Beta Bionics ( $BBNX ) to Buy with a price target of 26.
0 · Reply
JarvisFlow
JarvisFlow Jun. 12 at 12:30 PM
Lake Street has adjusted their stance on Beta Bionics ( $BBNX ), setting the rating to Buy with a target price of 30.
0 · Reply
1trendingup
1trendingup Jun. 2 at 6:14 PM
$BBNX lol been loading since low 10’s. Watch out $PODD we’re coming for you
0 · Reply
Kaibacorp
Kaibacorp May. 30 at 6:48 PM
$BBNX this is a $60 stock easy
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 30 at 3:35 PM
$BBNX Wolfe Research Initiates Coverage On Beta Bionics with Outperform Rating, Announces Price Target of $20
1 · Reply
Latest News on BBNX
Beta Bionics, Inc. (BBNX) Q1 2025 Earnings Call Transcript

May 10, 2025, 10:05 AM EDT - 7 weeks ago

Beta Bionics, Inc. (BBNX) Q1 2025 Earnings Call Transcript


Beta Bionics: Slowing Down Or Being Conservative?

Apr 24, 2025, 11:44 AM EDT - 2 months ago

Beta Bionics: Slowing Down Or Being Conservative?


Beta Bionics to Host Investor Event on June 22, 2025

Apr 9, 2025, 7:30 AM EDT - 2 months ago

Beta Bionics to Host Investor Event on June 22, 2025


Beta Bionics Announces Board Appointment of Gerard Michel

Mar 27, 2025, 4:45 PM EDT - 3 months ago

Beta Bionics Announces Board Appointment of Gerard Michel


Beta Bionics: A Sugar Rush For This IPO

Feb 2, 2025, 9:43 AM EST - 5 months ago

Beta Bionics: A Sugar Rush For This IPO


Beta Bionics Aims For IPO To Cover Heavy Losses

Jan 10, 2025, 11:36 AM EST - 6 months ago

Beta Bionics Aims For IPO To Cover Heavy Losses


Beta Bionics IPO Registration Document (S-1)

Jan 6, 2025, 4:25 PM EST - 6 months ago

Beta Bionics IPO Registration Document (S-1)


jheerdink
jheerdink Jun. 30 at 4:15 PM
$MODD Modular Medical (Nasdaq: MODD) Unveils Updated Investor Presentation, Emphasizing Disruptive Business Model and Near-Term Milestones https://vistapglobal.com/modular-medical-nasdaq-modd-unveils-updated-investor-presentation-emphasizing-disruptive-business-model-and-near-term-milestones/ $DXCM $BBNX
0 · Reply
P3acemaker
P3acemaker Jun. 25 at 10:05 PM
$BBNX holy shit look at the short interest on this baby - 18%!!!! Which would take 13 days to cover at current volume. Schwab says this stock is hard to borrow so it's not like they can stay short forever. This is an extremely bullish sign and partly accounts for the recent price drop IMO https://fintel.io/ss/us/bbnx
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 4:21 PM
$BBNX teams up with $ABT — is this the game-changer for diabetes care? 🤔 🔗 Strategic agreement to integrate iLet Bionic Pancreas with Abbott's dual glucose-ketone sensor 🚀 Aiming to enhance patient outcomes and simplify diabetes management 🏆 Positions BBNX to capture more of the growing AID market Opportunity assessment here 👉 https://www.zacks.com/commentary/2535909/bbnx-stock-may-gain-from-abbott-deal-to-advance-ilet-integration?cid=sm-stocktwits-2-2535909-body&ADID=SYND_STOCKTWITS_TWEET_2_2535909_BODY
0 · Reply
ZacksResearch
ZacksResearch Jun. 23 at 3:08 PM
$BBNX just teamed up with Abbott — here's why that matters 👀 Beta Bionics is integrating its iLet system with a dual sensor to simplify and improve diabetes care, a move that could drive adoption and upside. Full story on the potential impact here 👉 https://www.zacks.com/stock/news/2535909/bbnx-stock-may-gain-from-abbott-deal-to-advance-ilet-integration?cid=sm-stocktwits-2-2535909-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2535909_TEASER
0 · Reply
IN0V8
IN0V8 Jun. 16 at 8:25 PM
$BBNX Buying opportunity Truist Securities initiates coverage with buy rating Truist Securities initiates coverage with target price $26.00
0 · Reply
JarvisFlow
JarvisFlow Jun. 16 at 4:06 PM
Truist Securities has updated their rating for Beta Bionics ( $BBNX ) to Buy with a price target of 26.
0 · Reply
JarvisFlow
JarvisFlow Jun. 12 at 12:30 PM
Lake Street has adjusted their stance on Beta Bionics ( $BBNX ), setting the rating to Buy with a target price of 30.
0 · Reply
1trendingup
1trendingup Jun. 2 at 6:14 PM
$BBNX lol been loading since low 10’s. Watch out $PODD we’re coming for you
0 · Reply
Kaibacorp
Kaibacorp May. 30 at 6:48 PM
$BBNX this is a $60 stock easy
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee May. 30 at 3:35 PM
$BBNX Wolfe Research Initiates Coverage On Beta Bionics with Outperform Rating, Announces Price Target of $20
1 · Reply
StocktwitsNews
StocktwitsNews May. 30 at 4:34 AM
Beta Bionics Stock Gains After Mixed Analyst Coverage; Wolfe Bullish, Goldman Neutral $BBNX https://stocktwits.com/news/equity/markets/beta-bionics-stock-gains-after-mixed-analyst-coverage-wolfe-bullish-goldman-neutral/ch0MjxXRbMQ
0 · Reply
DonCorleone77
DonCorleone77 May. 30 at 1:15 AM
$BBNX Beta Bionics initiated with a Neutral at Goldman Sachs Goldman Sachs analyst David Roman initiated coverage of Beta Bionics with a Neutral rating and $16 price target as part of a broader research note launching coverage on Diabetes Medical Technology. Diabetes technology is poised to sustain double-digit growth, and Beta Bionics technology is well suited for a targeted segment of the Type 1 market, the analyst tells investors in a research note. Goldman Sachs added however that while the company's near-term growth should outpace Diabetes peers and SMID cap MedTech, consensus estimates seem to largely capture the opportunity over the next several years, with valuation reflecting both that level of growth and the need to raise capital down the road to achieve cash flow breakeven.
0 · Reply
jheerdink
jheerdink May. 28 at 9:25 PM
$MODD Please View our latest Tribe event video “Making Diabetes Management Simpler: The New Era of Insulin Therapy” Meet the CEO of Modular Medical $MODD and learn about MODD-1 and more https://youtu.be/7Y5eQv4QMyw?si=_iThdx8os69vWOcs #InsulinPumps Represent the gold standard in glycemic control $PODD $MDT $BBNX
0 · Reply
garygb
garygb May. 26 at 3:35 AM
$BBNX This could double.
2 · Reply
Kaibacorp
Kaibacorp May. 21 at 6:41 PM
$BBNX they sold a bunch more pumps I see this going real green next earnings pin it
0 · Reply
TradeIdeas1
TradeIdeas1 May. 19 at 5:07 PM
$BBNX EYES ON https://www.trade-ideas.com/share.php?code=bYrXdbdQsABmbVMc4EkCrYw39v4tVYPw #tradeideas #stocks #stockmarket #daytrading #investing #AISignals #PictureInPictureCharts
0 · Reply
im_ichiban
im_ichiban May. 9 at 10:51 AM
$EMBC Embecta Corp. (NASDAQ: EMBC) reported Q2 EPS of $0.70, $0.17 better than the analyst estimate of $0.53. Revenue for the quarter came in at $259 million versus the consensus estimate of $253.86 million. GUIDANCE: Embecta Corp. sees FY2025 EPS of $2.70-$2.90, versus the consensus of $2.82. Embecta Corp. sees FY2025 revenue of $1.07-1.09 billion, versus the consensus of $1.09 billion. $0.15 quarter dividend $BBNX $DXCM $QDEL
0 · Reply
Nicky23
Nicky23 May. 9 at 1:01 AM
$BBNX this will be a major player in the pump market. Flush with cash. Low shares out. Love this stock. Loaded up around 10. This will be a multi bagger over the next few years. Bank it.
0 · Reply
im_ichiban
im_ichiban May. 8 at 10:19 PM
$EMBC easy to see $17+ on good earning diabetes space hot $BBNX $DXCM $NVAX
1 · Reply
im_ichiban
im_ichiban May. 8 at 4:40 PM
$EMBC earning tomorrow $BBNX and $DXCM all good, diabetes hot!!!! $ABBV
0 · Reply
unionmoney
unionmoney May. 8 at 4:18 PM
$BBNX no talk here….. this one is a deep runner
0 · Reply
im_ichiban
im_ichiban May. 8 at 12:44 PM
$EMBC should doing good this quarter, both $BBNX and $DXCM reported blowout earnings $NVAX
0 · Reply